No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 3fcsD, 0.9443, 1.27, 0.105, 603, 237, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
2, 3zdxB, 0.9440, 1.28, 0.105, 464, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3, 3zdxD, 0.9439, 1.28, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
4, 3t3mB, 0.9439, 1.28, 0.105, 466, 237, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
5, 3fcsB, 0.9438, 1.28, 0.105, 680, 237, STRUCTURE OF COMPLETE ECTODOMAIN OF INTEGRIN AIIBB3
6, 3t3pB, 0.9437, 1.28, 0.105, 466, 237, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
7, 3nifB, 0.9437, 1.29, 0.105, 466, 237, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
8, 3nigB, 0.9434, 1.29, 0.105, 466, 237, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
9, 3nidB, 0.9434, 1.29, 0.105, 466, 237, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
10, 3t3mD, 0.9433, 1.29, 0.105, 471, 237, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
11, 3t3pD, 0.9431, 1.29, 0.105, 471, 237, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
12, 3zdyD, 0.9429, 1.30, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
13, 3nidD, 0.9429, 1.30, 0.105, 471, 237, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
14, 4g1mB, 0.9427, 1.29, 0.105, 692, 237, RE-REFINEMENT OF ALPHA V BETA 3 STRUCTURE
15, 3nigD, 0.9427, 1.30, 0.105, 471, 237, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
16, 3nifD, 0.9427, 1.30, 0.105, 467, 237, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
17, 3zdyB, 0.9423, 1.31, 0.105, 464, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
18, 4z7nD, 0.9419, 1.31, 0.105, 469, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
19, 3zdzD, 0.9419, 1.31, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
20, 3v4vD, 0.9417, 1.44, 0.139, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
21, 3v4vB, 0.9417, 1.44, 0.139, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
22, 4z7qD, 0.9416, 1.31, 0.105, 471, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
23, 4z7qB, 0.9415, 1.32, 0.105, 466, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
24, 3v4pD, 0.9415, 1.46, 0.139, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
25, 3v4pB, 0.9415, 1.46, 0.139, 375, 238, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
26, 4g1eB, 0.9414, 1.32, 0.105, 709, 237, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 3 WITH COIL-COILED TAG.
27, 4z7oD, 0.9406, 1.33, 0.105, 469, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
28, 4mmzB, 0.9406, 1.32, 0.105, 690, 237, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN
29, 5hdbD, 0.9403, 1.33, 0.105, 471, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
30, 5hdbB, 0.9402, 1.34, 0.105, 466, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
31, 3ze0D, 0.9394, 1.35, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
32, 4um9B, 0.9389, 1.57, 0.130, 448, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
33, 4o02B, 0.9389, 1.36, 0.105, 687, 237, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
34, 4um9D, 0.9387, 1.58, 0.130, 455, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE
35, 3ze1D, 0.9379, 1.37, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
36, 3ijeB, 0.9379, 1.40, 0.105, 695, 237, CRYSTAL STRUCTURE OF THE COMPLETE INTEGRIN ALHAVBETA3 ECTODOMAIN PLUS AN ALPHA/BETA TRANSMEMBRANE FRAGMENT
37, 4z7oB, 0.9374, 1.38, 0.105, 464, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
38, 3ze2B, 0.9368, 1.39, 0.105, 469, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
39, 1u8cB, 0.9360, 1.34, 0.110, 599, 236, A NOVEL ADAPTATION OF THE INTEGRIN PSI DOMAIN REVEALED FROM ITS CRYSTAL STRUCTURE
40, 1jv2B, 0.9360, 1.33, 0.110, 539, 236, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHAVBETA3
41, 1m1xB, 0.9350, 1.44, 0.105, 539, 237, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN ALPHA VBETA3 BOUND TO MN2+
42, 5ffgB, 0.9348, 1.67, 0.130, 248, 239, CRYSTAL STRUCTURE OF INTEGRIN ALPHA V BETA 6 HEAD
43, 4um8B, 0.9339, 1.68, 0.130, 423, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6
44, 4wk0B, 0.9334, 1.47, 0.131, 427, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
45, 4um8D, 0.9333, 1.69, 0.130, 414, 239, CRYSTAL STRUCTURE OF ALPHA V BETA 6
46, 3vi3D, 0.9331, 1.46, 0.131, 432, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
47, 4wjkB, 0.9326, 1.48, 0.131, 424, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
48, 6avqB, 0.9321, 1.45, 0.105, 688, 237, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
49, 6avrB, 0.9320, 1.45, 0.105, 685, 237, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
50, 5e6sF, 0.9320, 1.52, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
51, 5e6sD, 0.9320, 1.52, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
52, 3vi3B, 0.9320, 1.48, 0.131, 427, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
53, 5e6uB, 0.9318, 1.52, 0.105, 453, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
54, 4wk2B, 0.9318, 1.48, 0.131, 427, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
55, 5e6rB, 0.9315, 1.53, 0.105, 454, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
56, 4wk4B, 0.9314, 1.49, 0.131, 435, 236, METAL ION AND LIGAND BINDING OF INTEGRIN
57, 3vi4B, 0.9313, 1.49, 0.131, 431, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
58, 3vi4D, 0.9309, 1.49, 0.131, 433, 236, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
59, 6avuB, 0.9306, 1.48, 0.105, 461, 237, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
60, 4nenB, 0.9305, 1.53, 0.105, 665, 237, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
61, 5netB, 0.9299, 1.60, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE A.
62, 5nerB, 0.9299, 1.60, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A PRIME.
63, 5nemB, 0.9299, 1.60, 0.127, 448, 237, LOCALISED RECONSTRUCTION OF ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O PANASIA - POSE A.
64, 5e6sB, 0.9295, 1.55, 0.105, 455, 237, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
65, 5es4F, 0.9257, 1.60, 0.105, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
66, 5es4B, 0.9228, 1.62, 0.105, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
67, 5es4D, 0.9207, 1.66, 0.105, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
68, 5es4H, 0.9193, 1.69, 0.105, 674, 237, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
69, 4z7nB, 0.9190, 1.96, 0.105, 464, 237, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
70, 3zdzB, 0.9175, 1.96, 0.105, 464, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
71, 4nehB, 0.9173, 1.71, 0.105, 668, 237, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
72, 3ze0B, 0.9172, 1.96, 0.105, 465, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
73, 3ze1B, 0.9171, 1.96, 0.105, 464, 237, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
74, 3k71F, 0.9168, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
75, 3k71D, 0.9168, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
76, 3k71B, 0.9168, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
77, 3k71H, 0.9167, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
78, 3k6sF, 0.9167, 1.51, 0.106, 674, 235, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
79, 3k6sB, 0.9167, 1.51, 0.106, 674, 235, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
80, 3k6sD, 0.9166, 1.51, 0.102, 674, 235, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
81, 3k72D, 0.9165, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2
82, 3k6sH, 0.9165, 1.51, 0.102, 674, 235, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
83, 3k72B, 0.9164, 1.51, 0.106, 673, 235, STRUCTURE OF INTEGRIN ALPHAX BETA2
84, 5neuB, 0.9160, 1.72, 0.131, 448, 236, LOCALISED RECONSTRUCTION OF INTEGRIN ALPHA V BETA 6 BOUND TO FOOT AND MOUTH DISEASE VIRUS O1 MANISA - POSE B.
85, 1l5gB, 0.9130, 1.77, 0.105, 539, 237, CRYSTAL STRUCTURE OF THE EXTRACELLULAR SEGMENT OF INTEGRIN AVB3 IN COMPLEX WITH AN ARG-GLY-ASP LIGAND
86, 4mmyB, 0.9109, 1.94, 0.105, 690, 237, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF
87, 4mmxB, 0.9101, 1.98, 0.105, 690, 237, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
88, 5ffoB, 0.8916, 2.02, 0.106, 242, 236, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
89, 5ffoF, 0.8914, 2.02, 0.106, 242, 236, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
90, 3fcuF, 0.8880, 1.85, 0.090, 455, 233, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
91, 3fcuD, 0.8876, 1.85, 0.090, 455, 233, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
92, 3fcuB, 0.8875, 1.86, 0.090, 455, 233, STRUCTURE OF HEADPIECE OF INTEGRIN AIIBB3 IN OPEN CONFORMATION
93, 1tyeD, 0.8870, 1.86, 0.090, 440, 233, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
94, 3ze2D, 0.8866, 1.87, 0.090, 367, 233, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
95, 1tyeF, 0.8864, 1.87, 0.090, 440, 233, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
96, 2vdrB, 0.8858, 1.89, 0.090, 455, 233, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
97, 2vdoB, 0.8857, 1.89, 0.090, 455, 233, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
98, 2vdpB, 0.8856, 1.89, 0.090, 455, 233, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
99, 2vc2B, 0.8856, 1.89, 0.090, 457, 233, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
100, 2vdqB, 0.8855, 1.89, 0.090, 455, 233, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
101, 1tyeB, 0.8855, 1.88, 0.090, 440, 233, STRUCTURAL BASIS FOR ALLOSTERY IN INTEGRINS AND BINDING OF LIGAND- MIMETIC THERAPEUTICS TO THE PLATELET RECEPTOR FOR FIBRINOGEN
102, 2vdkB, 0.8854, 1.89, 0.090, 455, 233, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
103, 2vdnB, 0.8851, 1.90, 0.090, 455, 233, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
104, 2vdlB, 0.8850, 1.90, 0.090, 456, 233, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
105, 2vdmB, 0.8849, 1.90, 0.090, 456, 233, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
106, 6djpB, 0.8651, 1.44, 0.132, 353, 220, INTEGRIN ALPHA-V BETA-8 IN COMPLEX WITH THE FABS 8B8 AND 68 
107, 2iueA, 0.7783, 1.76, 0.094, 212, 203, PACTOLUS I-DOMAIN: FUNCTIONAL SWITCHING OF THE ROSSMANN FOLD
108, 4cakB, 0.7678, 2.53, 0.120, 680, 209, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
109, 2ww8A, 0.6279, 4.55, 0.099, 815, 212, STRUCTURE OF THE PILUS ADHESIN (RRGA) FROM STREPTOCOCCUS PNEUMONIAE
110, 3tvyA, 0.6221, 4.50, 0.100, 365, 209, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
111, 3txaA, 0.6212, 4.53, 0.085, 583, 211, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
112, 4cn9B, 0.6101, 2.98, 0.125, 396, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
113, 4cn9A, 0.6089, 3.00, 0.125, 397, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS WITH ZINC OCCUPIED MIDAS MOTIF
114, 6fvwCA, 0.6088, 2.68, 0.087, 197, 172, struct.pdbx_descriptor              
115, 4cnbB, 0.6088, 3.01, 0.119, 391, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
116, 4cnbA, 0.6085, 3.02, 0.125, 387, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS - CRYSTAL FORM 2
117, 4cn8A, 0.6071, 3.04, 0.125, 392, 176, STRUCTURE OF PROXIMAL THREAD MATRIX PROTEIN 1 (PTMP1) FROM THE MUSSEL BYSSUS
118, 6fvuCA, 0.6035, 2.80, 0.087, 197, 172, struct.pdbx_descriptor              
119, 6fvyCA, 0.6033, 2.97, 0.092, 197, 174, struct.pdbx_descriptor              
120, 5mpcIA, 0.6030, 2.96, 0.086, 197, 174, 
121, 6fvvCA, 0.6020, 2.94, 0.086, 197, 174, struct.pdbx_descriptor              
122, 5mpeW, 0.6013, 2.95, 0.092, 197, 174, 26S PROTEASOME IN PRESENCE OF ATP (S2)
123, 1sq0A, 0.5996, 3.28, 0.113, 198, 177, CRYSTAL STRUCTURE OF THE COMPLEX OF THE WILD-TYPE VON WILLEBRAND FACTOR A1 DOMAIN AND GLYCOPROTEIN IB ALPHA AT 2.6 ANGSTROM RESOLUTION
124, 6gym4, 0.5986, 3.31, 0.094, 297, 181, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
125, 6fvxCA, 0.5982, 2.96, 0.087, 197, 173, struct.pdbx_descriptor              
126, 1fnsA, 0.5976, 3.22, 0.114, 196, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
127, 3jcpFA, 0.5974, 3.08, 0.103, 197, 175, 
128, 1oakA, 0.5970, 3.22, 0.114, 196, 176, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
129, 6j30RA, 0.5966, 2.98, 0.104, 197, 173, struct.pdbx_descriptor              
130, 4cr4W, 0.5966, 2.92, 0.098, 197, 173, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
131, 6j2cRA, 0.5959, 2.97, 0.116, 197, 173, struct.pdbx_descriptor              
132, 6epdW, 0.5958, 2.90, 0.070, 195, 172, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
133, 3q3gL, 0.5958, 2.90, 0.122, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
134, 1ijbA, 0.5958, 3.28, 0.125, 202, 176, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN
135, 3jcoFA, 0.5957, 3.10, 0.103, 197, 175, 
136, 3hxoA, 0.5957, 3.26, 0.114, 199, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
137, 5mpbIA, 0.5954, 3.05, 0.086, 197, 174, 
138, 5oqm4, 0.5953, 3.30, 0.083, 297, 180, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
139, 5oqj4, 0.5953, 3.30, 0.083, 297, 180, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
140, 4c2bC, 0.5951, 3.27, 0.125, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
141, 3q3gG, 0.5946, 2.94, 0.122, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
142, 3hxqA, 0.5943, 3.29, 0.114, 201, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH DNA APTAMER ARC1172 AN INHIBITOR OF VWF-PLATELET BINDING
143, 5bv8A, 0.5941, 3.29, 0.108, 209, 176, G1324S MUTATION IN VON WILLEBRAND FACTOR A1 DOMAIN
144, 3tw0A, 0.5941, 4.36, 0.107, 361, 197, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
145, 3q3gE, 0.5941, 2.86, 0.123, 189, 171, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
146, 1ijkA, 0.5941, 3.29, 0.114, 199, 176, THE VON WILLEBRAND FACTOR MUTANT (I546V) A1 DOMAIN- BOTROCETIN COMPLEX
147, 4f1kB, 0.5940, 3.07, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
148, 4f1jA, 0.5940, 3.11, 0.082, 200, 171, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
149, 1uexC, 0.5940, 3.29, 0.119, 202, 176, CRYSTAL STRUCTURE OF VON WILLEBRAND FACTOR A1 DOMAIN COMPLEXED WITH SNAKE VENOM BITISCETIN
150, 1na5A, 0.5940, 2.99, 0.121, 195, 173, INTEGRIN ALPHA M I DOMAIN
151, 4f1kA, 0.5939, 3.06, 0.076, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ FREE VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
152, 4f1jB, 0.5938, 3.08, 0.071, 200, 170, CRYSTAL STRUCTURE OF THE MG2+ LOADED VWA DOMAIN OF PLASMODIUM FALCIPARUM TRAP PROTEIN
153, 4c2aA, 0.5938, 3.31, 0.108, 202, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH R1306Q AND I1309V MUTATIONS IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
154, 3tw0B, 0.5938, 4.54, 0.110, 361, 200, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
155, 1auqA, 0.5937, 3.30, 0.114, 208, 176, A1 DOMAIN OF VON WILLEBRAND FACTOR
156, 1aoxA, 0.5937, 3.07, 0.127, 201, 173, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
157, 6fvtCA, 0.5936, 2.96, 0.092, 197, 173, struct.pdbx_descriptor              
158, 4c2bA, 0.5936, 3.32, 0.125, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
159, 4c2bG, 0.5935, 3.30, 0.125, 197, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
160, 5hj2B, 0.5934, 3.07, 0.127, 196, 173, INTEGRIN ALPHA2BETA1 I-DOMAIN
161, 6fpzB, 0.5933, 3.28, 0.098, 598, 174, INTER-ALPHA-INHIBITOR HEAVY CHAIN 1; D298A 
162, 3q3gI, 0.5933, 2.96, 0.122, 189, 172, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
163, 6fpyB, 0.5931, 3.35, 0.097, 599, 175, INTER-ALPHA-INHIBITOR HEAVY CHAIN 1; WILD TYPE 
164, 4hqkA, 0.5930, 3.08, 0.065, 200, 170, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
165, 1u0oC, 0.5929, 3.29, 0.114, 195, 176, THE MOUSE VON WILLEBRAND FACTOR A1-BOTROCETIN COMPLEX
166, 1m10A, 0.5929, 3.22, 0.120, 199, 175, CRYSTAL STRUCTURE OF THE COMPLEX OF GLYCOPROTEIN IB ALPHA AND THE VON WILLEBRAND FACTOR A1 DOMAIN
167, 6j2nRA, 0.5925, 3.05, 0.116, 197, 173, struct.pdbx_descriptor              
168, 6fpyA, 0.5925, 3.36, 0.097, 600, 175, INTER-ALPHA-INHIBITOR HEAVY CHAIN 1; WILD TYPE 
169, 6fpzA, 0.5923, 3.37, 0.091, 598, 175, INTER-ALPHA-INHIBITOR HEAVY CHAIN 1; D298A 
170, 5l4kW, 0.5919, 3.19, 0.069, 196, 173, THE HUMAN 26S PROTEASOME LID
171, 3tw0C, 0.5919, 4.49, 0.111, 360, 198, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
172, 1mf7A, 0.5918, 3.02, 0.121, 194, 173, INTEGRIN ALPHA M I DOMAIN
173, 1u0nA, 0.5916, 3.30, 0.114, 207, 176, THE TERNARY VON WILLEBRAND FACTOR A1-GLYCOPROTEIN IBALPHA- BOTROCETIN COMPLEX
174, 4c2bE, 0.5915, 3.35, 0.119, 199, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION IN COMPLEX WITH HIGH AFFINITY GPIB ALPHA
175, 4c29B, 0.5915, 3.31, 0.119, 201, 176, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
176, 4c29A, 0.5915, 3.21, 0.120, 201, 175, CRYSTAL STRUCTURE OF HIGH-AFFINITY VON WILLEBRAND FACTOR A1 DOMAIN WITH DISULFIDE MUTATION
177, 5hj2F, 0.5914, 2.97, 0.129, 195, 171, INTEGRIN ALPHA2BETA1 I-DOMAIN
178, 4hqkB, 0.5913, 3.03, 0.065, 199, 169, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP P4212 FORM
179, 5hj2E, 0.5912, 3.12, 0.127, 196, 173, INTEGRIN ALPHA2BETA1 I-DOMAIN
180, 4cr2W, 0.5912, 2.88, 0.077, 197, 169, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
181, 5hj2C, 0.5900, 3.15, 0.127, 197, 173, INTEGRIN ALPHA2BETA1 I-DOMAIN
182, 5gjrP, 0.5899, 3.01, 0.093, 193, 172, 
183, 5gjrJB, 0.5899, 3.01, 0.093, 193, 172, 
184, 6o9m6, 0.5897, 2.88, 0.118, 385, 170, STRUCTURE OF THE HUMAN APO TFIIH 
185, 5es4A, 0.5896, 3.16, 0.121, 1080, 174, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
186, 5hgjA, 0.5895, 2.86, 0.141, 194, 170, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
187, 5gjqW, 0.5895, 3.02, 0.093, 193, 172, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
188, 4igiA, 0.5895, 2.99, 0.116, 197, 172, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN
189, 5a5bW, 0.5894, 3.11, 0.109, 197, 174, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
190, 4cr3W, 0.5894, 3.11, 0.109, 197, 174, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
191, 1pt6B, 0.5894, 2.90, 0.129, 195, 170, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
192, 5hj2A, 0.5890, 3.13, 0.128, 196, 172, INTEGRIN ALPHA2BETA1 I-DOMAIN
193, 1v7pC, 0.5890, 3.04, 0.129, 193, 171, STRUCTURE OF EMS16-ALPHA2-I DOMAIN COMPLEX
194, 5mpdW, 0.5888, 3.00, 0.092, 197, 173, 26S PROTEASOME IN PRESENCE OF ATP (S1)
195, 5ln1A, 0.5885, 3.06, 0.099, 188, 171, STRUCTURE OF UBIQUITYLATED-RPN10 FROM YEAST;
196, 5hj2D, 0.5882, 3.09, 0.128, 197, 172, INTEGRIN ALPHA2BETA1 I-DOMAIN
197, 4wfqA, 0.5880, 2.85, 0.089, 192, 169, CRYSTAL STRUCTURE OF TFIIH SUBUNIT
198, 3qa3G, 0.5878, 2.93, 0.112, 187, 170, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
199, 4ihkA, 0.5869, 3.05, 0.116, 193, 172, CRYSTAL STRUCTURE OF THE COLLAGEN VI ALPHA3 N5 DOMAIN R1061Q
200, 3k71G, 0.5868, 3.19, 0.109, 1082, 174, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
201, 3ppvA, 0.5863, 2.79, 0.090, 184, 166, CRYSTAL STRUCTURE OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
202, 3k6sA, 0.5863, 3.20, 0.109, 1082, 174, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
203, 3ppxA, 0.5856, 2.73, 0.090, 184, 166, CRYSTAL STRUCTURE OF THE N1602A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
204, 3ppwA, 0.5854, 2.73, 0.090, 184, 166, CRYSTAL STRUCTURE OF THE D1596A MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
205, 1jlmA, 0.5854, 2.86, 0.124, 187, 169, I-DOMAIN FROM INTEGRIN CR3 MN2+ BOUND
206, 3tw0D, 0.5852, 4.78, 0.112, 357, 206, STRUCTURAL ANALYSIS OF ADHESIVE TIP PILIN GBS104 FROM GROUP B STREPTOCOCCUS AGALACTIAE
207, 1bho1, 0.5851, 3.16, 0.121, 189, 173, MAC-1 I DOMAIN MAGNESIUM COMPLEX
208, 1n3yA, 0.5850, 3.11, 0.110, 189, 172, CRYSTAL STRUCTURE OF THE ALPHA-X BETA2 INTEGRIN I DOMAIN
209, 1bhq2, 0.5850, 3.11, 0.122, 189, 172, MAC-1 I DOMAIN CADMIUM COMPLEX
210, 5obzA, 0.5847, 3.36, 0.102, 200, 177, LOW RESOLUTION STRUCTURE OF THE P34CT/P44CT MINIMAL COMPLEX
211, 1aoxB, 0.5847, 3.15, 0.129, 201, 171, I DOMAIN FROM INTEGRIN ALPHA2-BETA1
212, 3ppyA, 0.5846, 2.74, 0.090, 187, 166, CRYSTAL STRUCTURE OF THE D1596A/N1602A DOUBLE MUTANT OF AN ENGINEERED VWF A2 DOMAIN (N1493C AND C1670S)
213, 1bhq1, 0.5845, 3.16, 0.110, 189, 173, MAC-1 I DOMAIN CADMIUM COMPLEX
214, 5vgzb, 0.5843, 3.18, 0.076, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
215, 5hgjB, 0.5843, 3.05, 0.135, 193, 170, STRUCTURE OF INTEGRIN ALPHA1BETA1 AND ALPHA2BETA1 I-DOMAINS EXPLAIN DIFFERENTIAL CALCIUM-MEDIATED LIGAND RECOGNITION
216, 1pt6A, 0.5843, 3.06, 0.118, 192, 169, I DOMAIN FROM HUMAN INTEGRIN ALPHA1-BETA1
217, 1idn2, 0.5843, 3.12, 0.116, 189, 172, MAC-1 I DOMAIN METAL FREE
218, 6j2qRA, 0.5838, 3.25, 0.087, 197, 172, struct.pdbx_descriptor              
219, 6mskH, 0.5837, 3.16, 0.093, 191, 172, struct.pdbx_descriptor               26S proteasome  
220, 5wvkRA, 0.5835, 3.28, 0.103, 197, 175, 
221, 1bho2, 0.5831, 3.15, 0.128, 189, 172, MAC-1 I DOMAIN MAGNESIUM COMPLEX
222, 6ro4D, 0.5829, 3.18, 0.110, 280, 173, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
223, 1idn1, 0.5828, 3.20, 0.116, 189, 173, MAC-1 I DOMAIN METAL FREE
224, 1qcyA, 0.5826, 2.85, 0.137, 193, 168, THE CRYSTAL STRUCTURE OF THE I-DOMAIN OF HUMAN INTEGRIN ALPHA1BETA1
225, 6nmiE, 0.5824, 3.19, 0.110, 366, 173, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
226, 1ck4B, 0.5821, 3.01, 0.129, 194, 170, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
227, 6nd9R, 0.5820, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
228, 6nd9O, 0.5819, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
229, 5thpF, 0.5818, 3.07, 0.129, 193, 170, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
230, 6ndgR, 0.5817, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
231, 6ndgO, 0.5817, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
232, 6ndcO, 0.5817, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
233, 5nusA, 0.5817, 3.22, 0.092, 210, 174, STRUCTURE OF A MINIMAL COMPLEX BETWEEN P44 AND P34 FROM CHAETOMIUM THERMOPHILUM
234, 6epeW, 0.5816, 3.03, 0.070, 195, 171, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
235, 4a0qA, 0.5816, 2.92, 0.131, 187, 168, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
236, 6nd8R, 0.5815, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
237, 6ndcR, 0.5814, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
238, 4a0qB, 0.5814, 2.97, 0.136, 192, 169, ACTIVATED CONFORMATION OF INTEGRIN ALPHA1 I-DOMAIN MUTANT
239, 6ndfR, 0.5813, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
240, 6ndfO, 0.5813, 2.90, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
241, 6nd8O, 0.5813, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
242, 3eh2B, 0.5813, 3.45, 0.080, 739, 175, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
243, 6nddR, 0.5812, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
244, 6nddO, 0.5812, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
245, 5kynB, 0.5812, 3.67, 0.096, 719, 178, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
246, 6ndhR, 0.5811, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
247, 6ndaR, 0.5811, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
248, 6ndaO, 0.5811, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
249, 6ndeO, 0.5810, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
250, 6ndbR, 0.5810, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
251, 6ndaI, 0.5810, 2.89, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
252, 6nd9F, 0.5810, 2.89, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
253, 6ndhO, 0.5809, 2.91, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
254, 6nd9I, 0.5809, 2.89, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
255, 6bxjA, 0.5809, 2.99, 0.137, 619, 168, STRUCTURE OF A SINGLE-CHAIN BETA3 INTEGRIN 
256, 6ndhF, 0.5808, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
257, 6ndcL, 0.5808, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
258, 6ndbO, 0.5808, 2.92, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
259, 6ndaF, 0.5808, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
260, 6ndhI, 0.5807, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
261, 6ndeR, 0.5807, 2.92, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
262, 6nd8F, 0.5807, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
263, 6nd8I, 0.5806, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
264, 6msjH, 0.5806, 3.04, 0.094, 191, 170, struct.pdbx_descriptor               26S proteasome  
265, 5oqm6, 0.5806, 3.14, 0.104, 335, 173, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH AND CORE MEDIATOR 
266, 5oqj6, 0.5806, 3.14, 0.104, 335, 173, STRUCTURE OF YEAST TRANSCRIPTION PRE-INITIATION COMPLEX WITH TFIIH 
267, 5iy93, 0.5806, 3.25, 0.121, 193, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
268, 5iy83, 0.5806, 3.25, 0.121, 193, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
269, 5iy63, 0.5806, 3.25, 0.121, 193, 174, HUMAN HOLO-PIC IN THE CLOSED STATE
270, 6ndcI, 0.5805, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
271, 6ndcF, 0.5805, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
272, 6ndgF, 0.5804, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
273, 6ndbI, 0.5804, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
274, 6ndhL, 0.5803, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
275, 6ndgI, 0.5803, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
276, 6ndbL, 0.5803, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
277, 6ndaL, 0.5803, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
278, 5kyyA, 0.5803, 3.68, 0.101, 716, 178, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
279, 4pn7A, 0.5803, 3.28, 0.097, 209, 175, CRYSTAL STRUCTURE OF THE TFIIH P34 N-TERMINAL DOMAIN
280, 6ndcC, 0.5802, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CHROMIUM BOUND 
281, 6nddF, 0.5801, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
282, 6ndbF, 0.5801, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
283, 6nd9L, 0.5801, 2.90, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
284, 6ndaC, 0.5800, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND CADMIUM 
285, 6nd8L, 0.5800, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
286, 3qa3I, 0.5800, 2.94, 0.119, 185, 168, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
287, 6ndhC, 0.5799, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND ZINC 
288, 6ndbC, 0.5799, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND COBALT 
289, 5iy73, 0.5799, 3.29, 0.109, 193, 175, HUMAN HOLO-PIC IN THE OPEN STATE
290, 6nddI, 0.5798, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
291, 6nd9C, 0.5798, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH CALCIUM 
292, 6ndgC, 0.5797, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
293, 6nd8C, 0.5797, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN AND BARIUM 
294, 6nddL, 0.5796, 2.91, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
295, 6nddC, 0.5796, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH MANGANESE BOUND 
296, 6mseH, 0.5796, 2.95, 0.072, 191, 167, struct.pdbx_descriptor               26S proteasome  
297, 5ivw3, 0.5795, 3.31, 0.109, 193, 175, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
298, 6ndfL, 0.5794, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
299, 6ndfI, 0.5794, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
300, 6ndfF, 0.5794, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
301, 1atzB, 0.5794, 3.17, 0.140, 189, 171, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
302, 6ndgL, 0.5793, 2.96, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH YTTRIUM BOUND 
303, 6ndeI, 0.5792, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
304, 6o9m4, 0.5790, 3.60, 0.111, 295, 180, STRUCTURE OF THE HUMAN APO TFIIH 
305, 6ndeF, 0.5790, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
306, 6gym6, 0.5790, 3.15, 0.104, 335, 173, STRUCTURE OF A YEAST CLOSED COMPLEX WITH DISTORTED DNA (CCDIST) 
307, 5vfqV, 0.5790, 3.06, 0.083, 191, 169, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
308, 5kyxA, 0.5790, 3.70, 0.101, 716, 178, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
309, 6ndfC, 0.5789, 2.97, 0.131, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH STRONTIUM 
310, 6ndeL, 0.5788, 2.92, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
311, 5of4E, 0.5788, 3.18, 0.110, 184, 172, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
312, 5vhfb, 0.5787, 3.28, 0.082, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
313, 5kywA, 0.5787, 3.71, 0.101, 714, 178, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
314, 6ndeC, 0.5786, 2.93, 0.132, 191, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN WITH PRASEDYMIUM 
315, 6bxbA, 0.5785, 2.91, 0.150, 463, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
316, 5vhhb, 0.5785, 3.29, 0.082, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
317, 2b2xA, 0.5785, 2.94, 0.120, 188, 167, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
318, 6o9l6, 0.5784, 3.16, 0.122, 385, 172, HUMAN HOLO-PIC IN THE CLOSED STATE 
319, 3efoA, 0.5784, 3.71, 0.101, 716, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
320, 5vfsV, 0.5783, 3.05, 0.071, 191, 169, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
321, 5kyuA, 0.5783, 3.62, 0.096, 716, 177, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
322, 1mhpB, 0.5783, 2.94, 0.120, 192, 167, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
323, 3qa3E, 0.5782, 2.91, 0.114, 186, 167, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
324, 3eg9A, 0.5782, 3.65, 0.102, 726, 177, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
325, 5vnhA, 0.5780, 3.73, 0.096, 707, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
326, 5vneA, 0.5780, 3.73, 0.096, 708, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
327, 3eh2A, 0.5779, 3.45, 0.057, 758, 175, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
328, 1qc5B, 0.5779, 2.81, 0.139, 190, 166, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
329, 1m2oA, 0.5779, 3.64, 0.107, 718, 177, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
330, 3egxA, 0.5778, 3.70, 0.096, 708, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
331, 1ck4A, 0.5777, 2.94, 0.120, 192, 167, CRYSTAL STRUCTURE OF RAT A1B1 INTEGRIN I-DOMAIN.
332, 3qa3L, 0.5776, 3.02, 0.113, 185, 168, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
333, 5vnoA, 0.5773, 3.74, 0.096, 703, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
334, 4dmuH, 0.5773, 3.16, 0.141, 187, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
335, 1qc5A, 0.5773, 2.82, 0.139, 192, 166, I DOMAIN FROM INTEGRIN ALPHA1-BETA1
336, 3egdA, 0.5772, 3.72, 0.096, 711, 178, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
337, 5iy90, 0.5771, 3.35, 0.109, 188, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE (NO IIS)
338, 5iy80, 0.5771, 3.35, 0.109, 188, 174, HUMAN HOLO-PIC IN THE INITIAL TRANSCRIBING STATE
339, 5iy70, 0.5771, 3.35, 0.109, 188, 174, HUMAN HOLO-PIC IN THE OPEN STATE
340, 5iy60, 0.5771, 3.35, 0.109, 188, 174, HUMAN HOLO-PIC IN THE CLOSED STATE
341, 1m2oC, 0.5771, 3.65, 0.113, 718, 177, CRYSTAL STRUCTURE OF THE SEC23-SAR1 COMPLEX
342, 6bxfA, 0.5770, 2.95, 0.150, 463, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
343, 4dmuJ, 0.5770, 3.15, 0.141, 191, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
344, 4bziA, 0.5770, 3.71, 0.107, 733, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
345, 2qtvA, 0.5770, 3.71, 0.107, 733, 178, STRUCTURE OF SEC23-SAR1 COMPLEXED WITH THE ACTIVE FRAGMENT OF SEC31
346, 5vniA, 0.5769, 3.66, 0.096, 707, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
347, 5kyuB, 0.5768, 3.47, 0.091, 764, 175, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE2 COMPLEX
348, 6gniA, 0.5767, 3.74, 0.112, 733, 178, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
349, 5thpC, 0.5767, 2.97, 0.132, 190, 167, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
350, 4bziG, 0.5767, 3.74, 0.112, 733, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
351, 4bziD, 0.5767, 3.74, 0.112, 733, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
352, 6o9l4, 0.5766, 3.56, 0.094, 295, 180, HUMAN HOLO-PIC IN THE CLOSED STATE 
353, 5vnlA, 0.5766, 3.73, 0.096, 699, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
354, 5vnjA, 0.5766, 3.72, 0.096, 697, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
355, 5ivw0, 0.5766, 3.35, 0.109, 188, 174, HUMAN CORE TFIIH BOUND TO DNA WITHIN THE PIC
356, 1mhpA, 0.5766, 2.98, 0.131, 184, 168, CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY
357, 2nutA, 0.5765, 3.72, 0.096, 708, 178, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
358, 1ao3B, 0.5765, 3.17, 0.141, 187, 170, A3 DOMAIN OF VON WILLEBRAND FACTOR
359, 6msgH, 0.5764, 3.21, 0.088, 191, 171, struct.pdbx_descriptor               26S proteasome  
360, 5kyxB, 0.5764, 3.58, 0.080, 767, 176, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE1 COMPLEX
361, 2nupA, 0.5764, 3.72, 0.096, 699, 178, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
362, 1m2vA, 0.5764, 3.66, 0.102, 705, 177, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
363, 5vnnA, 0.5763, 3.73, 0.096, 699, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
364, 5vftb, 0.5763, 3.01, 0.077, 191, 168, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
365, 5t0hb, 0.5763, 3.01, 0.077, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
366, 4dmuD, 0.5763, 3.16, 0.141, 188, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
367, 4dmuL, 0.5762, 3.17, 0.141, 188, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
368, 4dmuB, 0.5761, 3.18, 0.141, 188, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
369, 5vnmA, 0.5760, 3.73, 0.096, 698, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
370, 6ckbA, 0.5759, 3.07, 0.143, 464, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
371, 5vhib, 0.5759, 3.33, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
372, 5vnkA, 0.5758, 3.74, 0.096, 708, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
373, 2x5nA, 0.5758, 2.99, 0.084, 188, 167, CRYSTAL STRUCTURE OF THE SPRPN10 VWA DOMAIN
374, 5vhsb, 0.5757, 3.32, 0.088, 191, 171, CONFORMATIONAL LANDSCAPE OF THE P28-BOUND HUMAN PROTEASOME REGULATORY PARTICLE
375, 4dmuF, 0.5757, 3.18, 0.141, 188, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A COLLAGEN III DERIVED TRIPLE-HELICAL PEPTIDE
376, 5vngA, 0.5756, 3.74, 0.096, 696, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
377, 5vnfA, 0.5755, 3.74, 0.096, 707, 178, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
378, 4xw2A, 0.5755, 3.01, 0.143, 184, 168, STRUCTURAL BASIS FOR SIMVASTATIN COMPETITIVE ANTAGONISM OF COMPLEMENT RECEPTOR 3
379, 2adfA, 0.5752, 3.18, 0.140, 189, 171, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
380, 1ao3A, 0.5752, 3.17, 0.135, 187, 170, A3 DOMAIN OF VON WILLEBRAND FACTOR
381, 5thpI, 0.5751, 3.12, 0.137, 191, 168, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
382, 6mshH, 0.5749, 3.23, 0.088, 191, 171, struct.pdbx_descriptor               26S proteasome  
383, 5kynA, 0.5749, 3.75, 0.096, 730, 178, STRUCTURE OF SEC23 AND TANGO1 COMPLEX
384, 5wviT, 0.5747, 3.39, 0.081, 197, 172, 
385, 5thpO, 0.5747, 2.87, 0.133, 191, 165, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
386, 1atzA, 0.5746, 3.13, 0.136, 184, 169, HUMAN VON WILLEBRAND FACTOR A3 DOMAIN
387, 6bxfB, 0.5743, 2.96, 0.150, 464, 167, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN L33 
388, 1zonA, 0.5740, 2.89, 0.145, 181, 166, CD11A I-DOMAIN WITHOUT BOUND CATION
389, 3zqkC, 0.5738, 2.77, 0.098, 178, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
390, 6ergD, 0.5733, 3.96, 0.093, 503, 182, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
391, 5t0gb, 0.5732, 3.08, 0.071, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
392, 5t0cNA, 0.5732, 3.08, 0.071, 191, 168, 
393, 5t0cH, 0.5732, 3.08, 0.071, 191, 168, 
394, 6j2xRA, 0.5729, 3.41, 0.099, 197, 171, struct.pdbx_descriptor              
395, 3zqkA, 0.5729, 2.78, 0.092, 181, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
396, 5of4F, 0.5728, 3.64, 0.135, 205, 178, THE CRYO-EM STRUCTURE OF HUMAN TFIIH
397, 6ergA, 0.5727, 4.01, 0.104, 501, 183, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
398, 1m1uA, 0.5727, 2.98, 0.143, 184, 168, AN ISOLEUCINE-BASED ALLOSTERIC SWITCH CONTROLS AFFINITY AND SHAPE SHIFTING IN INTEGRIN CD11B A-DOMAIN
399, 1jeqA, 0.5725, 3.81, 0.094, 548, 180, CRYSTAL STRUCTURE OF THE KU HETERODIMER
400, 6bxbB, 0.5724, 2.90, 0.139, 465, 166, CRYSTAL STRUCTURE OF AN EXTENDED B3 INTEGRIN P33 
401, 1fe8C, 0.5723, 3.29, 0.153, 187, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
402, 6nmiF, 0.5722, 3.71, 0.116, 263, 181, CRYO-EM STRUCTURE OF THE HUMAN TFIIH CORE COMPLEX 
403, 6epcW, 0.5722, 3.25, 0.081, 195, 172, GROUND STATE 26S PROTEASOME (GS2)
404, 1n9zA, 0.5722, 3.06, 0.143, 184, 168, INTEGRIN ALPHA M I DOMAIN MUTANT
405, 5vfuH, 0.5720, 3.07, 0.065, 191, 168, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
406, 5t0ib, 0.5720, 3.07, 0.065, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
407, 1pcxA, 0.5720, 3.48, 0.133, 745, 173, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN BET1
408, 5vfpU, 0.5719, 3.04, 0.060, 191, 168, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
409, 6ckbB, 0.5718, 3.15, 0.143, 465, 168, CRYSTAL STRUCTURE OF AN EXTENDED BETA3 INTEGRIN P33 
410, 3zqkB, 0.5717, 2.79, 0.098, 178, 163, VON WILLEBRAND FACTOR A2 DOMAIN WITH CALCIUM
411, 5e6sE, 0.5716, 3.28, 0.137, 580, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
412, 1idoA, 0.5716, 3.00, 0.143, 184, 168, I-DOMAIN FROM INTEGRIN CR3 MG2+ BOUND
413, 6ro4E, 0.5708, 3.61, 0.107, 237, 178, STRUCTURE OF THE CORE TFIIH-XPA-DNA COMPLEX 
414, 6msdH, 0.5701, 3.11, 0.077, 191, 169, struct.pdbx_descriptor               26S proteasome  
415, 5e6sA, 0.5701, 3.30, 0.131, 578, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
416, 5thpL, 0.5699, 3.08, 0.127, 189, 166, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
417, 5kywB, 0.5697, 3.97, 0.089, 766, 180, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE3 COMPLEX
418, 1fe8B, 0.5697, 3.31, 0.153, 186, 170, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
419, 5kyyB, 0.5696, 4.01, 0.083, 767, 181, CRYSTAL STRUCTURE OF SEC23 AND TANGO1 PEPTIDE4 COMPLEX
420, 3f78C, 0.5696, 3.04, 0.133, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
421, 3efoB, 0.5696, 3.92, 0.083, 767, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF SYNTAXIN 5
422, 5e6uA, 0.5695, 3.31, 0.131, 583, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
423, 3eg9B, 0.5693, 3.93, 0.083, 767, 180, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23/24 BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF MEMBRIN
424, 5y58A, 0.5691, 4.49, 0.085, 548, 189, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
425, 3f74C, 0.5691, 3.10, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
426, 6msbH, 0.5690, 3.16, 0.065, 191, 169, struct.pdbx_descriptor               26S proteasome  
427, 5thpR, 0.5690, 2.87, 0.121, 187, 165, RHODOCETIN IN COMPLEX WITH THE INTEGRIN ALPHA2-A DOMAIN
428, 5y58E, 0.5688, 4.43, 0.085, 548, 188, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
429, 6epfW, 0.5684, 3.42, 0.086, 195, 174, GROUND STATE 26S PROTEASOME (GS1)
430, 1fe8A, 0.5684, 3.17, 0.155, 186, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
431, 5y58C, 0.5683, 4.42, 0.085, 548, 188, CRYSTAL STRUCTURE OF KU70/80 AND TLC1
432, 5e6rA, 0.5683, 3.30, 0.131, 581, 168, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
433, 3gxbB, 0.5682, 2.90, 0.092, 177, 163, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
434, 3eh2C, 0.5680, 3.57, 0.063, 739, 174, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24C
435, 5t0jb, 0.5678, 3.12, 0.071, 191, 168, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
436, 3gxbA, 0.5678, 2.91, 0.092, 177, 163, CRYSTAL STRUCTURE OF VWF A2 DOMAIN
437, 2i6qA, 0.5675, 3.64, 0.102, 503, 176, COMPLEMENT COMPONENT C2A
438, 1jeyA, 0.5671, 3.90, 0.095, 493, 179, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
439, 3f78B, 0.5662, 3.12, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
440, 2odpA, 0.5662, 3.77, 0.102, 490, 177, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
441, 3f74A, 0.5659, 3.11, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
442, 1dgqA, 0.5657, 3.16, 0.139, 188, 166, NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1
443, 1pd0A, 0.5656, 3.88, 0.130, 734, 177, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE FROM THE SNARE PROTEIN SED5 (YEAST SYNTAXIN-5)
444, 3f74B, 0.5655, 3.14, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN
445, 5vnnB, 0.5653, 3.42, 0.070, 731, 171, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (50MM SOAKING)
446, 6gniE, 0.5652, 3.91, 0.129, 735, 178, CRYO-TOMOGRAPHY AND SUBTOMOGRAM AVERAGING OF SAR1-SEC23-SEC24 - FITTED MODEL. 
447, 4bziM, 0.5652, 3.91, 0.129, 735, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
448, 4bziL, 0.5652, 3.91, 0.129, 735, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
449, 4bziE, 0.5652, 3.91, 0.129, 735, 178, THE STRUCTURE OF THE COPII COAT ASSEMBLED ON MEMBRANES
450, 1m2vB, 0.5652, 3.91, 0.129, 748, 178, CRYSTAL STRUCTURE OF THE YEAST SEC23/24 HETERODIMER
451, 2odqA, 0.5651, 3.88, 0.101, 492, 178, COMPLEMENT COMPONENT C2A THE CATALYTIC FRAGMENT OF C3- AND C5- CONVERTASE OF HUMAN COMPLEMENT
452, 5vnjB, 0.5650, 3.42, 0.070, 731, 171, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FF SORTING MOTIF (ERGIC-53)
453, 3f78A, 0.5649, 3.14, 0.145, 180, 166, CRYSTAL STRUCTURE OF WILD TYPE LFA1 I DOMAIN COMPLEXED WITH ISOFLURANE
454, 5o85C, 0.5647, 3.39, 0.104, 198, 173, P34-P44 COMPLEX
455, 4m76B, 0.5646, 2.96, 0.127, 179, 165, INTEGRIN I DOMAIN OF COMPLEMENT RECEPTOR 3 IN COMPLEX WITH C3D
456, 1pd1A, 0.5646, 3.89, 0.130, 735, 177, CRYSTAL STRUCTURE OF THE COPII COAT SUBUNIT SEC24 COMPLEXED WITH A PEPTIDE CONTAINING THE DXE CARGO SORTING SIGNAL OF YEAST SYS1 PROTEIN
457, 6erhC, 0.5643, 3.99, 0.083, 493, 180, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
458, 6erfE, 0.5639, 4.00, 0.106, 497, 180, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
459, 2m32A, 0.5637, 3.41, 0.136, 192, 169, ALPHA-1 INTEGRIN I-DOMAIN IN COMPLEX WITH GLOGEN TRIPLE HELICAL PEPTIDE
460, 5e6sC, 0.5632, 3.21, 0.133, 578, 166, STRUCTURES OF LEUKOCYTE INTEGRIN ALB2: THE AI DOMAIN THE HEADPIECE AND THE POCKET FOR THE INTERNAL LIGAND
461, 1mjnA, 0.5628, 2.99, 0.160, 179, 163, CRYSTAL STRUCTURE OF THE INTERMEDIATE AFFINITY AL I DOMAIN MUTANT
462, 4nehA, 0.5626, 3.26, 0.132, 1084, 167, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
463, 5ln3W, 0.5624, 3.07, 0.079, 185, 164, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
464, 6erfC, 0.5623, 3.95, 0.107, 500, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
465, 4hqoB, 0.5623, 3.50, 0.126, 260, 167, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
466, 5o85A, 0.5621, 3.48, 0.127, 190, 173, P34-P44 COMPLEX
467, 3ibsB, 0.5621, 3.24, 0.120, 199, 166, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
468, 3ibsA, 0.5621, 3.23, 0.120, 200, 166, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN BATB FROM BACTEROIDES THETAIOTAOMICRON
469, 2i6sA, 0.5621, 3.54, 0.110, 497, 172, COMPLEMENT COMPONENT C2A
470, 4nenA, 0.5613, 3.32, 0.132, 1063, 167, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
471, 4hqnB, 0.5603, 3.55, 0.126, 256, 167, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
472, 2x31C, 0.5603, 3.09, 0.097, 187, 165, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
473, 2x31D, 0.5602, 3.06, 0.091, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
474, 6erfA, 0.5600, 3.93, 0.107, 493, 177, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
475, 6erfD, 0.5599, 4.05, 0.080, 520, 176, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
476, 4hqlB, 0.5599, 3.56, 0.126, 256, 167, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
477, 4hqfA, 0.5594, 3.69, 0.076, 200, 171, CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM TRAP I4 FORM
478, 4okrB, 0.5593, 3.01, 0.130, 236, 161, STRUCTURES OF TOXOPLASMA GONDII MIC2
479, 3egdB, 0.5592, 3.88, 0.080, 731, 176, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22 AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF VESICULAR STOMATITIS VIRUS GLYCOPROTEIN
480, 5vneB, 0.5589, 3.89, 0.080, 729, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH EMP24 SORTING MOTIF
481, 5vnlB, 0.5587, 3.92, 0.080, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (1MM SOAKING)
482, 2nupB, 0.5587, 3.90, 0.080, 731, 176, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
483, 5vnhB, 0.5583, 3.90, 0.080, 729, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL SV SORTING MOTIF
484, 5vnfB, 0.5583, 3.91, 0.080, 729, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL VV SORTING MOTIF
485, 1jeqB, 0.5582, 4.08, 0.068, 520, 176, CRYSTAL STRUCTURE OF THE KU HETERODIMER
486, 2nutB, 0.5581, 4.01, 0.079, 729, 177, CRYSTAL STRUCTURE OF THE HUMAN SEC23A/24A HETERODIMER COMPLEXED WITH THE SNARE PROTEIN SEC22B
487, 6erfB, 0.5580, 4.14, 0.090, 521, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
488, 5vngB, 0.5580, 3.92, 0.080, 728, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL II SORTING MOTIF
489, 5vnkB, 0.5578, 4.00, 0.079, 729, 177, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL LL SORTING MOTIF
490, 6erfF, 0.5577, 4.13, 0.090, 526, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
491, 5y3rB, 0.5577, 3.50, 0.094, 526, 170, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
492, 5vnoB, 0.5577, 3.92, 0.080, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22
493, 3eoaI, 0.5577, 2.94, 0.143, 179, 161, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
494, 5vnmB, 0.5576, 3.92, 0.080, 731, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH 4- PHENYLBUTYRIC ACID (15MM SOAKING)
495, 3eobI, 0.5576, 3.03, 0.161, 179, 161, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
496, 3egxB, 0.5576, 3.93, 0.080, 729, 176, CRYSTAL STRUCTURE OF THE MAMMALIAN COPII-COAT PROTEIN SEC23A/24A COMPLEXED WITH THE SNARE PROTEIN SEC22B AND BOUND TO THE TRANSPORT SIGNAL SEQUENCE OF THE SNARE PROTEIN BET1
497, 5vniB, 0.5575, 3.94, 0.080, 727, 176, CRYSTAL STRUCTURE OF SEC23A/SEC24A/SEC22 COMPLEXED WITH A C-TERMINAL FA SORTING MOTIF
498, 6erfH, 0.5574, 4.15, 0.090, 526, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
499, 6erfG, 0.5574, 4.01, 0.118, 495, 178, COMPLEX OF APLF FACTOR AND KU HETERODIMER BOUND TO DNA 
500, 3jbrF, 0.5574, 3.45, 0.107, 872, 169, CRYO-EM STRUCTURE OF THE RABBIT VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT 4.2 ANGSTROM
501, 3bqmB, 0.5573, 3.18, 0.153, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
502, 2o7nA, 0.5573, 3.25, 0.147, 180, 163, CD11A (LFA1) I-DOMAIN COMPLEXED WITH 7A-[(4-CYANOPHENYL) METHYL]-6-(35-DICHLOROPHENYL)-5-OXO-2357A-TETRAHYDRO- 1H-PYRROLO[12-A]PYRROLE-7-CARBONITRILE
503, 3m6fA, 0.5572, 3.38, 0.146, 180, 164, CD11A I-DOMAIN COMPLEXED WITH 6-((5S9R)-9-(4-CYANOPHENYL)-3-(35- DICHLOROPHENYL)-1-METHYL-24-DIOXO-137- TRIAZASPIRO[4.4]NON-7-YL) NICOTINIC ACID
504, 1jeyB, 0.5572, 4.13, 0.090, 530, 178, CRYSTAL STRUCTURE OF THE KU HETERODIMER BOUND TO DNA
505, 3bqnB, 0.5571, 3.17, 0.160, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
506, 2x31B, 0.5571, 3.10, 0.098, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
507, 1xuoA, 0.5570, 3.20, 0.146, 181, 164, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
508, 4okuB, 0.5569, 2.97, 0.131, 241, 160, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
509, 2x31E, 0.5568, 3.13, 0.098, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
510, 3hi6A, 0.5564, 3.23, 0.127, 180, 165, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
511, 3bqnC, 0.5563, 3.18, 0.135, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
512, 3eoaJ, 0.5562, 2.99, 0.150, 179, 160, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
513, 3bqmC, 0.5562, 3.18, 0.141, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
514, 2icaA, 0.5562, 3.03, 0.137, 179, 161, CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S 9R)-9-(4-CYANOPHENYL)-3-(35-DICHLOROPHENYL)-1-METHYL-24- DIOXO-137-TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3- THIOPHENECARBOXYLICACID
515, 3eobJ, 0.5559, 3.09, 0.148, 179, 162, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
516, 6erhA, 0.5557, 4.01, 0.101, 490, 178, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
517, 4hqnA, 0.5557, 3.43, 0.127, 254, 165, CRYSTAL STRUCTURE OF MANGANESE-LOADED PLASMODIUM VIVAX TRAP PROTEIN
518, 4hqlA, 0.5557, 3.44, 0.127, 254, 165, CRYSTAL STRUCTURE OF MAGNESIUM-LOADED PLASMODIUM VIVAX TRAP PROTEIN
519, 1zopB, 0.5557, 3.19, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
520, 1zopA, 0.5557, 3.19, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
521, 1zooB, 0.5557, 3.19, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
522, 3hi6B, 0.5556, 3.17, 0.128, 180, 164, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
523, 1zooA, 0.5556, 3.19, 0.141, 183, 163, CD11A I-DOMAIN WITH BOUND MAGNESIUM ION
524, 1xddA, 0.5556, 3.14, 0.148, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
525, 1shtX, 0.5556, 3.44, 0.119, 177, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
526, 1rd4C, 0.5555, 3.15, 0.160, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
527, 1rd4D, 0.5554, 3.16, 0.154, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
528, 1rd4B, 0.5554, 3.15, 0.160, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
529, 1rd4A, 0.5554, 3.15, 0.160, 184, 162, AN ALLOSTERIC INHIBITOR OF LFA-1 BOUND TO ITS I-DOMAIN
530, 4hqoA, 0.5553, 3.53, 0.096, 257, 166, CRYSTAL STRUCTURE OF PLASMODIUM VIVAX TRAP PROTEIN
531, 4ixdA, 0.5551, 3.05, 0.142, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH IBE-667 AT 1.8A RESOLUTION
532, 3e2mB, 0.5551, 3.21, 0.141, 182, 163, LFA-1 I DOMAIN BOUND TO INHIBITORS
533, 1xddB, 0.5551, 3.15, 0.148, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA703 AT 2.2A RESOLUTION
534, 1lfaA, 0.5551, 3.06, 0.142, 183, 162, CD11A I-DOMAIN WITH BOUND MN++
535, 4fx5A, 0.5547, 3.22, 0.120, 415, 166, VON WILLEBRAND FACTOR TYPE A FROM CATENULISPORA ACIDIPHILA
536, 1lfaB, 0.5545, 3.07, 0.142, 182, 162, CD11A I-DOMAIN WITH BOUND MN++
537, 3e2mA, 0.5543, 3.10, 0.149, 182, 161, LFA-1 I DOMAIN BOUND TO INHIBITORS
538, 6cesD, 0.5541, 4.34, 0.060, 901, 183, CRYO-EM STRUCTURE OF GATOR1-RAG
539, 3eh1A, 0.5538, 3.88, 0.080, 737, 175, CRYSTAL STRUCTURE OF THE HUMAN COPII-COAT PROTEIN SEC24B
540, 1shuX, 0.5538, 3.48, 0.107, 181, 168, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A DOMAIN OF HUMAN CAPILLARY MORPHOGENESIS PROTEIN 2: AN ANTHRAX TOXIN RECEPTOR
541, 2x31A, 0.5537, 3.24, 0.097, 187, 165, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
542, 1xuoB, 0.5535, 2.98, 0.151, 175, 159, X-RAY STRUCTURE OF LFA-1 I-DOMAIN BOUND TO A 14-DIAZEPANE- 25-DIONE INHIBITOR AT 1.8A RESOLUTION
543, 1cqpA, 0.5534, 3.12, 0.155, 182, 161, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
544, 2x31F, 0.5530, 3.15, 0.091, 187, 164, MODELLING OF THE COMPLEX BETWEEN SUBUNITS BCHI AND BCHD OF MAGNESIUM CHELATASE BASED ON SINGLE-PARTICLE CRYO-EM RECONSTRUCTION AT 7.5 ANG
545, 3tcxT, 0.5526, 3.27, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
546, 3tcxD, 0.5526, 3.27, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
547, 1xdgA, 0.5526, 3.23, 0.142, 182, 162, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
548, 3tcxZ, 0.5525, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
549, 3tcxL, 0.5525, 3.27, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
550, 3tcxF, 0.5525, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
551, 3tcxB, 0.5525, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
552, 3tcxb, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
553, 3tcxX, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
554, 3tcxR, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
555, 3tcxP, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
556, 3tcxN, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
557, 3tcxJ, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
558, 3tcxH, 0.5524, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
559, 1xdgB, 0.5524, 3.16, 0.137, 182, 161, X-RAY STRUCTURE OF LFA-1 I-DOMAIN IN COMPLEX WITH LFA878 AT 2.1A RESOLUTION
560, 1dziA, 0.5524, 3.11, 0.130, 185, 162, INTEGRIN ALPHA2 I DOMAIN / COLLAGEN COMPLEX
561, 1cqpB, 0.5524, 3.23, 0.142, 182, 162, CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION
562, 3tcxV, 0.5522, 3.28, 0.152, 180, 165, STRUCTURE OF ENGINEERED SINGLE DOMAIN ICAM-1 D1 WITH HIGH-AFFINITY AL INTEGRIN I DOMAIN OF NATIVE C-TERMINAL HELIX CONFORMATION
563, 2b2xB, 0.5519, 2.95, 0.125, 176, 160, VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB
564, 1tzno, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
565, 1tznm, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
566, 1tznl, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
567, 1tznk, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
568, 1tznj, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
569, 1tzni, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
570, 1tznh, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
571, 1tzng, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
572, 1tznf, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
573, 1tzne, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
574, 1tznd, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
575, 1tznc, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
576, 1tznb, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
577, 1tzna, 0.5517, 3.58, 0.112, 181, 169, CRYSTAL STRUCTURE OF THE ANTHRAX TOXIN PROTECTIVE ANTIGEN HEPTAMERIC PREPORE BOUND TO THE VWA DOMAIN OF CMG2 AN ANTHRAX TOXIN RECEPTOR
578, 6cetD, 0.5516, 4.22, 0.061, 901, 180, CRYO-EM STRUCTURE OF GATOR1
579, 6adrR, 0.5511, 3.55, 0.101, 185, 169, ANTHRAX TOXIN RECEPTOR 1-BOUND THE SENECA VALLEY VIRUS IN NEUTRAL CONDITIONS 
580, 5m6wL, 0.5509, 4.04, 0.103, 505, 175, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
581, 5vfrb, 0.5501, 3.18, 0.072, 191, 166, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
582, 4bj3A, 0.5498, 3.09, 0.130, 183, 161, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
583, 2winL, 0.5498, 4.03, 0.103, 507, 175, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
584, 2winK, 0.5498, 4.03, 0.103, 507, 175, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
585, 2winJ, 0.5498, 4.03, 0.103, 507, 175, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
586, 2winI, 0.5498, 4.03, 0.103, 507, 175, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
587, 5m6wJ, 0.5492, 3.96, 0.115, 505, 174, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
588, 5gjvF, 0.5491, 3.38, 0.113, 941, 168, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX AT NEAR ATOMIC RESOLUTION
589, 6admR, 0.5489, 3.61, 0.071, 185, 168, ANTHRAX TOXIN RECEPTOR 1-BOUND FULL PARTICLES OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
590, 3n2nF, 0.5487, 3.53, 0.113, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
591, 3n2nD, 0.5480, 3.63, 0.118, 185, 169, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
592, 1rs0A, 0.5480, 3.76, 0.111, 480, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
593, 3n2nE, 0.5478, 3.53, 0.113, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
594, 3n2nA, 0.5476, 3.56, 0.113, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
595, 3n2nB, 0.5475, 3.57, 0.113, 185, 168, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
596, 1rtkA, 0.5474, 3.77, 0.111, 486, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
597, 4jduA, 0.5472, 2.95, 0.082, 193, 159, THE CRYSTAL STRUCTURE OF AN AEROTOLERANCE-RELATED MEMBRANE PROTEIN FROM BACTEROIDES FRAGILIS NCTC 9343 WITH MULTIPLE MUTATIONS TO SERINES.
598, 1rrkA, 0.5470, 3.77, 0.111, 480, 171, CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
599, 3n2nC, 0.5455, 3.69, 0.118, 185, 169, THE CRYSTAL STRUCTURE OF TUMOR ENDOTHELIAL MARKER 8 (TEM8) EXTRACELLULAR DOMAIN
600, 6cx1E, 0.5450, 3.71, 0.118, 182, 169, CRYO-EM STRUCTURE OF SENECA VALLEY VIRUS-ANTHRAX TOXIN RECEPTOR 1 COMPLEX 
601, 2xwjJ, 0.5449, 4.00, 0.099, 713, 172, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
602, 1t0pA, 0.5444, 2.94, 0.152, 174, 158, STRUCTURAL BASIS OF ICAM RECOGNITION BY INTEGRIN ALPAHLBETA2 REVEALED IN THE COMPLEX STRUCTURE OF BINDING DOMAINS OF ICAM-3 AND ALPHALBETA2 AT 1.65 A
603, 2xwjK, 0.5437, 4.09, 0.110, 713, 173, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
604, 1t6bY, 0.5437, 3.29, 0.123, 170, 163, CRYSTAL STRUCTURE OF B. ANTHRACIS PROTECTIVE ANTIGEN COMPLEXED WITH HUMAN ANTHRAX TOXIN RECEPTOR
605, 2xwjI, 0.5429, 4.21, 0.103, 712, 174, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
606, 6ergE, 0.5428, 3.82, 0.095, 536, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
607, 6ergB, 0.5428, 3.81, 0.095, 531, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
608, 3hs0D, 0.5427, 3.74, 0.107, 699, 168, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
609, 2xwjL, 0.5426, 4.22, 0.103, 711, 174, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
610, 5gjwF, 0.5423, 3.42, 0.095, 941, 168, STRUCTURE OF THE MAMMALIAN VOLTAGE-GATED CALCIUM CHANNEL CAV1.1 COMPLEX FOR CLASSII MAP
611, 1mqaA, 0.5423, 3.08, 0.158, 174, 158, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN IN THE ABSENCE OF LIGAND OR METAL
612, 2xwbF, 0.5419, 3.92, 0.105, 714, 171, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
613, 6erhB, 0.5417, 3.83, 0.095, 534, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
614, 1mq9A, 0.5417, 3.00, 0.134, 173, 157, CRYSTAL STRUCTURE OF HIGH AFFINITY ALPHAL I DOMAIN WITH LIGAND MIMETIC CRYSTAL CONTACT
615, 4bj3B, 0.5415, 2.96, 0.127, 179, 157, INTEGRIN ALPHA2 I DOMAIN E318W-COLLAGEN COMPLEX
616, 6erhD, 0.5405, 3.89, 0.095, 535, 169, COMPLEX OF XLF AND HETERODIMER KU BOUND TO DNA 
617, 3hs0I, 0.5405, 3.77, 0.101, 704, 168, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
618, 2xwbH, 0.5405, 3.98, 0.105, 711, 171, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
619, 4okrA, 0.5395, 3.36, 0.133, 235, 158, STRUCTURES OF TOXOPLASMA GONDII MIC2
620, 3hrzD, 0.5392, 3.82, 0.101, 693, 168, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
621, 2ok5A, 0.5391, 3.55, 0.085, 710, 164, HUMAN COMPLEMENT FACTOR B
622, 5a8jA, 0.5389, 3.69, 0.121, 365, 165, CRYSTAL STRUCTURE OF THE ARNB PARALOG VWA2 FROM SULFOLOBUS ACIDOCALDARIUS
623, 4okuA, 0.5378, 3.35, 0.133, 240, 158, STRUCTURE OF TOXOPLASMA GONDII PROMIC2
624, 1mq8D, 0.5375, 3.45, 0.122, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
625, 1mq8B, 0.5373, 3.46, 0.122, 177, 164, CRYSTAL STRUCTURE OF ALPHAL I DOMAIN IN COMPLEX WITH ICAM-1
626, 1q0pA, 0.5275, 3.45, 0.094, 192, 160, A DOMAIN OF FACTOR B
627, 3bn3A, 0.5238, 2.71, 0.154, 180, 149, CRYSTAL STRUCTURE OF ICAM-5 IN COMPLEX WITH AL I DOMAIN
628, 2nvoA, 0.5043, 3.66, 0.108, 496, 157, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS RO (RSR) PROTEIN
629, 5y3rA, 0.5029, 4.58, 0.081, 493, 172, CRYO-EM STRUCTURE OF HUMAN DNA-PK HOLOENZYME
